Erdal Sağ

2.0k total citations
83 papers, 966 citations indexed

About

Erdal Sağ is a scholar working on Molecular Biology, Hematology and Rheumatology. According to data from OpenAlex, Erdal Sağ has authored 83 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 28 papers in Hematology and 26 papers in Rheumatology. Recurrent topics in Erdal Sağ's work include Autoimmune and Inflammatory Disorders Research (25 papers), Inflammasome and immune disorders (25 papers) and Kawasaki Disease and Coronary Complications (16 papers). Erdal Sağ is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (25 papers), Inflammasome and immune disorders (25 papers) and Kawasaki Disease and Coronary Complications (16 papers). Erdal Sağ collaborates with scholars based in Türkiye, United States and United Kingdom. Erdal Sağ's co-authors include Seza Özen, Yelda Bilginer, Selcan Demir, Ezgi Deniz Batu, Seza Özen, Ümmüşen Kaya Akça, Erdal Atalay, Hafize Emine Sönmez, Fatma Dedeoğlu and Stephen D. Marks and has published in prestigious journals such as PEDIATRICS, Science Advances and Frontiers in Immunology.

In The Last Decade

Erdal Sağ

73 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erdal Sağ Türkiye 20 350 341 302 216 186 83 966
Selcan Demir Türkiye 18 375 1.1× 267 0.8× 305 1.0× 222 1.0× 235 1.3× 71 925
Timuçin Kaşifoğlu Türkiye 16 426 1.2× 317 0.9× 290 1.0× 128 0.6× 125 0.7× 80 873
Fabrizia Corona Italy 17 259 0.7× 325 1.0× 193 0.6× 154 0.7× 337 1.8× 53 1.0k
Nuray Aktay Ayaz Türkiye 17 598 1.7× 274 0.8× 371 1.2× 257 1.2× 350 1.9× 135 1.1k
Isabelle Melki France 15 275 0.8× 268 0.8× 285 0.9× 221 1.0× 156 0.8× 69 875
Luciana Breda Italy 17 224 0.6× 306 0.9× 252 0.8× 163 0.8× 421 2.3× 51 906
Meral Koniçe Türkiye 18 179 0.5× 496 1.5× 235 0.8× 95 0.4× 161 0.9× 38 934
Emilio B. González United States 19 105 0.3× 448 1.3× 211 0.7× 108 0.5× 152 0.8× 46 1.0k
Mathilde de Menthon France 12 136 0.4× 400 1.2× 188 0.6× 168 0.8× 81 0.4× 26 1.1k
A. Masseau France 20 145 0.4× 562 1.6× 244 0.8× 171 0.8× 183 1.0× 84 1.2k

Countries citing papers authored by Erdal Sağ

Since Specialization
Citations

This map shows the geographic impact of Erdal Sağ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erdal Sağ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erdal Sağ more than expected).

Fields of papers citing papers by Erdal Sağ

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erdal Sağ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erdal Sağ. The network helps show where Erdal Sağ may publish in the future.

Co-authorship network of co-authors of Erdal Sağ

This figure shows the co-authorship network connecting the top 25 collaborators of Erdal Sağ. A scholar is included among the top collaborators of Erdal Sağ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erdal Sağ. Erdal Sağ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Başaran, Özge, et al.. (2025). Validation of the EULAR/ACR classification criteria for chronic nonbacterial osteomyelitis in a pediatric cohort. Clinical Rheumatology. 44(10). 4229–4236.
2.
Sağ, Erdal, et al.. (2025). Re-evaluation of MEFV carriers previously diagnosed with FMF: a colchicine discontinuation study. Lara D. Veeken. 64(11). 5726–5732.
3.
Sağ, Erdal, Lieselotte Vande Walle, Ayşenur Paç Kısaarslan, et al.. (2025). Transcriptome analysis of unmedicated heterozygous familial Mediterranean fever patients reveals a type I interferon signature driving increasing Pyrin expression. Annals of the Rheumatic Diseases. 84(11). 1928–1937.
4.
Temizoz, Burcu, Tomoya Hayashi, Kouji Kobiyama, et al.. (2024). 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation. Frontiers in Immunology. 15. 1353336–1353336. 14 indexed citations
5.
Akça, Ümmüşen Kaya, Erdal Sağ, Büşra Aydın, et al.. (2023). Chronic non-bacterial osteomyelitis and immune checkpoint molecules. Clinical Rheumatology. 43(1). 553–560.
6.
Batu, Ezgi Deniz, Erdal Sağ, Lovro Lamot, et al.. (2023). The impact of the COVID-19 pandemic on pediatric rheumatology practice: an international, cross-sectional survey study. Seminars in Arthritis and Rheumatism. 63. 152289–152289.
7.
Sözeri, Betül, Ferhat Demir, Kenan Barut, et al.. (2023). Evaluation of clinical outcomes in systemic juvenile idiopathic arthritis patients treated with biological agents in Turkey: the TURSIS study. Clinical and Experimental Rheumatology. 42(1). 194–201. 3 indexed citations
8.
Yayla, Burcu Ceylan Cura, et al.. (2022). Hyperimmunoglobulin D Syndrome Presenting with Volvulus Due to Abdominal Fibro-Inflammatory Bands. Turkish Archives of Pediatrics. 58(1). 109–111. 1 indexed citations
9.
Gürlevik, Sibel Laçinel, Yasemin Özsürekçi, Erdal Sağ, et al.. (2022). The difference of the inflammatory milieu in MIS-C and severe COVID-19. Pediatric Research. 92(6). 1805–1814. 25 indexed citations
10.
Akça, Ümmüşen Kaya, et al.. (2021). POS1298 COMPARISON OF FMF CLINICAL FEATURES BETWEEN TURKISH AND CRIMEAN TATAR CHILDREN. Annals of the Rheumatic Diseases. 80. 930–931. 1 indexed citations
11.
Akça, Ümmüşen Kaya, Hayrettin Hakan Aykan, Erdal Sağ, et al.. (2021). Comparison of IVIG resistance predictive models in Kawasaki disease. Pediatric Research. 91(3). 621–626. 19 indexed citations
12.
Akça, Ümmüşen Kaya, Erdal Sağ, Şule Ünal, et al.. (2021). The role of vascular inflammation markers in deficiency of adenosine deaminase 2. Seminars in Arthritis and Rheumatism. 51(4). 839–844. 6 indexed citations
13.
Cüceoğlu, Müşerref Kasap, Seher Şener, Ezgi Deniz Batu, et al.. (2021). Systematic review of childhood-onset polyarteritis nodosa and DADA2. Seminars in Arthritis and Rheumatism. 51(3). 559–564. 12 indexed citations
14.
Kadayıfçılar, Sibel, Selcan Demir, Erdal Sağ, et al.. (2021). Assessment of systemic and ocular inflammation in juvenile idiopathic arthritis via choroidal vascularity index. Rheumatology International. 42(7). 1187–1196. 9 indexed citations
15.
Batu, Ezgi Deniz, Ümmüşen Kaya Akça, Ayşenur Paç Kısaarslan, et al.. (2020). The Performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 Classification Criteria in Pediatric Systemic Lupus Erythematosus. The Journal of Rheumatology. 48(6). 907–914. 30 indexed citations
16.
Sağ, Erdal, Erdal Atalay, Selcan Demir, et al.. (2020). Performances of the “MS-score” And “HScore” in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients. Rheumatology International. 41(1). 87–93. 5 indexed citations
17.
Demir, Selcan, Erdal Sağ, Fatma Dedeoğlu, & Seza Özen. (2018). Vasculitis in Systemic Autoinflammatory Diseases. Frontiers in Pediatrics. 6. 377–377. 40 indexed citations
18.
Sağ, Erdal, Ezgi Deniz Batu, & Seza Özen. (2017). Childhood systemic vasculitis. Best Practice & Research Clinical Rheumatology. 31(4). 558–575. 16 indexed citations
19.
Yasin, Shireena A., Katie Arnold, Erdal Sağ, et al.. (2014). Sub-phenotyping of juvenile dermatomyositis: can it assist clinical decisions?. Pediatric Rheumatology. 12(S1). 2 indexed citations
20.
Ünal, Şule, Erdal Sağ, Barış Kuşkonmaz, et al.. (2013). Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab. Pediatric Blood & Cancer. 61(5). 928–930. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Selcan Demir Breakdown of academic impact, for papers by Timuçin Kaşifoğlu Breakdown of academic impact, for papers by Fabrizia Corona Breakdown of academic impact, for papers by Nuray Aktay Ayaz Breakdown of academic impact, for papers by Isabelle Melki Breakdown of academic impact, for papers by Luciana Breda Breakdown of academic impact, for papers by Meral Koniçe Breakdown of academic impact, for papers by Emilio B. González Breakdown of academic impact, for papers by Mathilde de Menthon Breakdown of academic impact, for papers by A. Masseau
Rankless by CCL
2026